EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Narrative Review: Intestinal α‐Syn Oligomers as a Novel Pharmacological Target for Parkinson's Disease

Qian Shen, Anran Lv iD, Yaxin Li, Peizhi Liu, Jibao Yang, Shaoxia Wang, Hong Guo

Neurogastroenterology & Motility · 2026-03 · 38 (3)

DOI: 10.1111/nmo.70289 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 17.03.2026. Verfasst von Qian Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 152 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons and neurological dysfunctions. The aggregation of abnormal α‐synuclein (α‐Syn) is closely associated with neuronal damage and acts as the major pathogenic driver mediating neurotoxicity. As critical intermediates in the aggregation cascade, α‐Syn oligomers are regarded as the most neurotoxic species, which are widely distributed in both the central and peripheral nervous systems and contribute to the initiation and progression of PD. The gut‐brain axis has attracted increasing attention, with a focus on the generation and propagation of gut‐derived α‐Syn oligomers, which can be promoted by chronic gut inflammation, gut microbiota dysbiosis, genetic mutations, and environmental factors. In this paper, we systematically elaborate on the formation of α‐Syn oligomers and their transmission into the central nervous system, discuss existing therapeutic strategies targeting α‐Syn oligomers, and analyze emerging prospects for future interventions.

Results

This review integrates and analyzes available evidence regarding the biogenesis, gut‐to‐brain propagation, and pathogenic roles of α‐Syn oligomers in PD. It also summarizes the current progress of therapeutic approaches targeting α‐Syn oligomers and evaluates their potential value.

Conclusion

This review not only provides novel insights into pathogenetic mechanisms of PD but also highlights the therapeutic feasibility of targeting gut‐derived α‐Syn oligomers as a potential strategy for PD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseHumansAnimalsGastrointestinal Microbiome

Stichwörter der Autor:innen

Parkinson's diseaseneurotoxicitythe gut‐brain axisα‐Syn oligomers

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

ORCID-Profile: Anran Lv

Zitieren

APA

Shen, Q., Lv, A., Li, Y., Liu, P., Yang, J., Wang, S., & Guo, H. (2026). Narrative Review: Intestinal α‐Syn Oligomers as a Novel Pharmacological Target for Parkinson's Disease. Neurogastroenterology & Motility, 38(3). https://doi.org/10.1111/nmo.70289

Vancouver

Shen Q, Lv A, Li Y, Liu P, Yang J, Wang S, et al. Narrative Review: Intestinal α‐Syn Oligomers as a Novel Pharmacological Target for Parkinson's Disease. Neurogastroenterology & Motility. 2026;38(3). doi:10.1111/nmo.70289

BibTeX
@article{Shen2026,
  author = {Shen, Qian and Lv, Anran and Li, Yaxin and Liu, Peizhi and Yang, Jibao and Wang, Shaoxia and Guo, Hong},
  title = {Narrative Review: Intestinal α‐Syn Oligomers as a Novel Pharmacological Target for Parkinson's Disease},
  journal = {Neurogastroenterology & Motility},
  year = {2026},
  volume = {38},
  number = {3},
  doi = {10.1111/nmo.70289}
}
Kostenlos starten →